###begin article-title 0
###xml 37 41 <span type="species:ncbi:10090">Mice</span>
Lack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet-Induced Metabolic Disease
###end article-title 0
###begin p 1
###xml 32 51 32 51 <email xmlns:xlink="http://www.w3.org/1999/xlink">hong.lan@spcorp.com</email>
Corresponding author: Hong Lan, hong.lan@spcorp.com
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 717 722 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 722 725 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
OBJECTIVE-FFAR1/GPR40 is a G-protein-coupled receptor expressed predominantly in pancreatic islets mediating free fatty acid-induced insulin secretion. However, the physiological role of FFAR1 remains controversial. It was previously reported that FFAR1 knockout (Ffar1-/-) mice were resistant to high-fat diet-induced hyperinuslinemia, hyperglycemia, hypertriglyceridemia, and hepatic steatosis. A more recent report suggested that although FFAR1 was necessary for fatty acid-induced insulin secretion in vivo, deletion of FFAR1 did not protect pancreatic islets against fatty acid-induced islet dysfunction. This study is designed to investigate FFAR1 function in vivo using a third line of independently generated Ffar1-/- mice in the C57BL/6 background.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 181 186 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 186 189 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 206 211 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 211 214 208 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-We used CL-316,243, a beta3 adrenergic receptor agonist, to acutely elevate blood free fatty acids and to study its effect on insulin secretion in vivo. Ffar1+/+ (wild-type) and Ffar1-/- (knockout) mice were placed on two distinct high-fat diets to study their response to diet-induced obesity.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 61 66 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 66 69 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 189 194 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 194 197 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 202 207 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 207 210 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 291 296 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 296 299 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 454 459 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 459 462 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 467 472 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 472 475 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
RESULTS-Insulin secretion was reduced by approximately50% in Ffar1-/- mice, confirming that FFAR1 contributes significantly to fatty acid stimulation of insulin secretion in vivo. However, Ffar1+/+ and Ffar1-/- mice had similar weight, adiposity, and hyperinsulinemia on high-fat diets, and Ffar1-/- mice showed no improvement in glucose or insulin tolerance tests. In addition, high-fat diet induced comparable levels of lipid accumulation in livers of Ffar1+/+ and Ffar1-/- mice.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
CONCLUSIONS-FFAR1 is required for normal insulin secretion in response to fatty acids; however, Ffar1-/- mice are not protected from high-fat diet-induced insulin resistance or hepatic steatosis.
###end p 6
###begin p 7
Published ahead of print at  on 4 August 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
Fatty acids are involved in a diverse array of physiological functions in a variety of tissues. Many of the effects of fatty acids are thought to be mediated by intracellular metabolites of long-chain acyl-CoA esters. Evidence has accumulated over the last few years, however, that at least some of the activities attributed to fatty acids are mediated through their interaction with a number of G-protein-coupled receptors designated FFAR1 (GPR40), FFAR2 (GPR43), FFAR3 (GPR41), GPR120, and GPR84. FFAR2 and FFAR3 are activated by short-chain fatty acids, whereas FFAR1, GPR84, and GPR120 are activated by medium- to long-chain fatty acids (1). Among these receptors, FFAR1 and GPR120 have drawn attention for their potential as therapeutic targets for metabolic disease (2-4).
###end p 9
###begin p 10
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 827 830 827 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1035 1036 1035 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1081 1086 1081 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1086 1089 1086 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1113 1118 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1118 1121 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1316 1321 1304 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1321 1324 1309 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1486 1491 1474 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1491 1494 1479 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1600 1601 1588 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1733 1734 1721 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 295 310 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1325 1329 <span type="species:ncbi:10090">mice</span>
###xml 1364 1368 <span type="species:ncbi:10090">mice</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
Interest in FFAR1 intensified in 2005 when Steneberg et al. (5) reported that mice lacking FFAR1 were resistant to a number of the effects of a high-fat diet, including hyperinuslinemia, hyperglycemia, hypertriglyceridemia, and hepatic steatosis. Conversely, Steneberg et al. also reported that transgenic mice overexpressing FFAR1 in pancreatic islets developed diabetes, suggesting that sustained signaling through FFAR1 could be detrimental. Although it is known that fatty acids are important for insulin secretion in normal individuals, it is also widely recognized that chronically elevated fatty acids contribute to pancreatic dysfunction (6). In this regard, Steneberg et al. observed that insulin secretion from isolated Ffar1-/- islets was not impaired by 48-h exposure to palmitic acid (5). They concluded that Ffar1-/- islets are protected from the long-term negative effect of fatty acids and suggested that FFAR1 antagonists might be used to prevent and treat obesity-associated type 2 diabetes. Recently, Latour et al. (7) reported the characterizations of a second Ffar1-/- line. They showed that Ffar1-/- mice had a approximately50% reduction in acute insulin secretion in response to a bolus of injected Intralipid. Although Latour et al. did not report on the effects of high-fat feeding in their Ffar1-/- mice, they observed that male knockout mice on a chow diet developed significant (albeit slight) glucose intolerance. They also showed that isolated islets from Ffar1-/- mice were still subject to the impairment of the insulin response after chronic exposure to fatty acids (7). Except for the role of FFAR1 in mediating insulin secretion, these findings stand in contrast to the report of Steneberg et al. (5).
###end p 10
###begin p 11
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 283 284 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 349 350 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 371 374 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 366 374 354 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>&#8722;/&#8722;</sup></italic>
###xml 447 450 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 442 450 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>&#8722;/&#8722;</sup></italic>
###xml 587 592 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 592 595 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
Here, we report metabolic phenotypes on a third, independent line of Ffar1-/- mice generated in the C57BL/6Ncrl (B6) background. We found that FFAR1 contributes to approximately50% of fatty acid-mediated insulin release in vivo, consistent with the previous report of Latour et al. (7). In contrast to the previous observations by Steneberg et al. (5), however, our Ffar1-/- mice are not protected from the negative effects of high-fat diet. Ffar1-/- mice on a high-fat diet became obese, developed insulin resistance, and accumulated liver lipids to a similar extent when compared with Ffar1+/+ littermates. Taken together, our data confirm that FFAR1 is important for fatty acid-mediated insulin secretion, but call into question its role in mediating the toxic effects of free fatty acids on metabolic diseases.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin title 13
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Generation of Ffar1-/- mice in C57BL/6NCrl (B6) background.
###end title 13
###begin p 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 595 597 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/</sup>
###xml 597 598 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 963 966 963 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1016 1019 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1057 1062 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1062 1065 1062 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1072 1077 1072 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1077 1080 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
Ffar1-/- mice were custom-generated by DeltaGen (Palo Alto, CA). Briefly, a targeting vector was designed to delete a 152-bp fragment corresponding to position 143-294 of the open reading frame of the Ffar1 gene (NM_194057). This segment was replaced with a Neomycin (neo) cassette. The vector was electroporated into 129/OlaHsd-derived embryo stem (ES) cells, and G418-resistant ES cell colonies were then picked and expanded for DNA analysis. The correctly targeted ES cells were injected into blastocysts to generate chimeric mice that were then mated to B6 females. Ffar1 heterozygous (Ffar1+/-) offspring were identified by a PCR-based screening strategy. The PCR primers were designed to detect both wild-type (234-bp) and knockout (399-bp) alleles. Oligonucleotide sequences were as follows: Ffar1 upstream of the deleted region forward, 5'-cccagcttggtctacactctccatc-3'; Ffar1 downstream of the deleted region reverse, 5'-gatggcttggtacccgaaggggaag-3'; and neo forward, 5'-gggtgggattagataaatgcctgctct-3'. Ffar1+/- mice were then interbred to generate Ffar1-/- mice. Ffar1-/- mice were backcrossed to C57BL/6NCrl mice for >10 generations to generate mice in a B6 background.
###end p 14
###begin title 15
In vivo insulin secretion in response to acutely elevated free fatty acids.
###end title 15
###begin p 16
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 171 172 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 305 306 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 861 865 833 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plex</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
Nonfasted Ffar1+/+ and Ffar1-/- mice, age and sex matched, received intraperitoneal injection of either saline or the beta3-agonist CL-316,243 (Sigma-Aldrich) at 1 mg/kg (8). Fifteen minutes after injection, approximately700 mul blood was collected from each mouse by cardiac puncture immediately after CO2 asphyxiation. To preserve glucagon-like peptide 1 (GLP-1), DPP-IV inhibitor (Linco) was added to precooled blood collection tubes (BD Microtainer 365974; Becton Dickinson, Franklin Lakes, NJ) and plasma isolated by centrifugation at 5,000 rpm for 10 min while maintaining a temperature of 4degreesC. Aliquots of plasma samples were stored at -80degreesC until analysis. Plasma levels of insulin and GLP-1 (7-36)amide were estimated using kits from Meso Scale Discovery (Gaithersburg, MD). Leptin, amylin, and glucagon levels were measured using the Lincoplex Luminex kits (Linco Research, St. Charles, MO). Glucose, free fatty acids, and triglycerides were measured using commercial kits from Wako Diagnostics (Richmond, VA).
###end p 16
###begin title 17
High-fat diet-feeding studies.
###end title 17
###begin p 18
###xml 770 771 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1080 1081 1072 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">Mice</span>
All mice under study were weaned onto Lab Rodent Diet 20 (4.5% fat; PMI Nutrition International) and, unless specified, were group housed in polycarbonate cages in a specific pathogen-free environment on a 12-h light/dark cycle at a temperature of 22degreesC. In one study, mice at N6 generation of backcrossing into B6 background were fed for 8 weeks with a Surwit diabetogenic diet (58% of calories from lard) or a semipurified low-fat diet (D12450B; 10% of calories from fat; Research Diets, New Brunswick, NJ) ad libitum. In a separate study, mice at >/=N10 of backcrossing into B6 background were fed with a semipurified diet with 60% calories from fat (Research Diets). Body composition was assessed by nuclear magnet resonance spectroscopy. Mice were killed by CO2 asphyxiation for blood and tissue collection after 4 h fasting. Plasma glucose, fatty acid, and triglyceride levels were measured as described above. Liver neutral lipids (cholesterol ester, free cholesterol, and triglyceride) were analyzed by high-performance liquid chromatography as previously described (9). All studies were conducted in an American Association for Laboratory Animal Care-accredited facility, according to protocols approved by the Schering-Plough Research Institute Animal Care and Use Committee.
###end p 18
###begin title 19
Glucose and insulin tolerance test.
###end title 19
###begin p 20
Blood was collected after 16 h of fasting, and basal glucose levels were measured using a glucose oxidase method (Glucometer Elite; Bayer, Elkhart, IN). After this measure, glucose (3 g/kg body wt) or insulin (0.75 mU/g body wt) was administered by intraperitoneal injection, and blood was collected from the tail vein at 20, 40, 60, 90, and 120 min after dose for glucose determination.
###end p 20
###begin title 21
Data analysis.
###end title 21
###begin p 22
###xml 150 151 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 271 272 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are reported as means +/- SE. Statistical analyses were performed with GraphPad Prism (version 4.00; GraphPad Software) using unpaired Student's t tests, one-way ANOVA, or two-way ANOVA, depending on data structures. Specific methods used are indicated in the text. P values <0.05 are considered statistically significant.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin p 24
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 505 512 505 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 562 565 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 604 607 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 697 700 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 768 775 768 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 783 786 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1031 1034 1031 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1039 1044 1039 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1044 1047 1044 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
To generate Ffar1-/- mice, a segment of the gene encoding part of the second transmembrane domain, all of the first extracellular domain, and part of the third transmembrane domain of the FFAR1 protein was targeted by homologous recombination (Fig. 1A). Targeted ES cells were first screened by PCR, and positive clones were identified by Southern blotting using probes that hybridize outside of and adjacent to the targeting construct arms. Ffar1-/- mice were derived from a positive ES clone (ES 1315) (Fig. 1B). Examples of PCR genotypes from individual Ffar1+/+ (wild-type), Ffar1+/- (Het), and Ffar1-/- (knockout) mice are shown in Fig. 1C. As assessed by real-time quantitative RT-PCR, Ffar1-/- mice lack Ffar1 mRNA expression in pancreatic islets or in spleen (Fig. 1D). Ffar1-/- mice were born at the expected 1:2:1 Mendelian ratio and appeared healthy and fertile, and no abnormalities were detected on gross examination. Under chow-feeding conditions, we observed no overt difference in metabolic phenotypes between Ffar1+/+ and Ffar1-/- mice.
###end p 24
###begin title 25
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Fatty acid-stimulated insulin secretion was attenuated in Ffar1-/- mice in vivo.
###end title 25
###begin p 26
###xml 200 202 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 374 375 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 427 432 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 432 435 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 440 445 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 445 448 442 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 668 669 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 752 758 749 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 828 833 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 833 836 830 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 841 846 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 846 849 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 892 893 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 935 940 932 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 940 943 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 948 953 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 953 956 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 996 997 993 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1027 1028 1024 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1134 1139 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1139 1142 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1155 1156 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1149 1156 1143 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1162 1167 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1167 1170 1161 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1292 1293 1274 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1286 1293 1268 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1303 1308 1285 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1308 1311 1290 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1380 1385 1362 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1385 1388 1367 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1443 1444 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1437 1444 1419 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1446 1447 1428 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1456 1461 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1461 1464 1443 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1480 1485 1462 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1485 1488 1467 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1501 1502 1483 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1763 1768 1733 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1768 1771 1738 1741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1839 1840 1809 1810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1833 1840 1803 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1891 1896 1849 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1896 1899 1854 1857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2283 2284 2238 2239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2277 2284 2232 2239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 2286 2287 2241 2242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2399 2400 2354 2355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2420 2421 2375 2376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2619 2624 2574 2579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2624 2627 2579 2582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2674 2675 2629 2630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 2668 2675 2623 2630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 2677 2678 2632 2633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2687 2692 2642 2647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2692 2695 2647 2650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2711 2716 2666 2671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2716 2719 2671 2674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2739 2740 2694 2695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2782 2787 2737 2742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2787 2790 2742 2745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2842 2847 2797 2802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2847 2850 2802 2805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2857 2858 2812 2813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2867 2872 2822 2827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2872 2875 2827 2830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2891 2896 2846 2851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 2896 2899 2851 2854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2923 2924 2878 2879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3027 3029 2978 2980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 3118 3119 3069 3070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 3112 3119 3063 3070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 3172 3173 3123 3124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3182 3183 3133 3134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3259 3264 3210 3215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 3264 3267 3215 3218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3308 3313 3259 3264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 3313 3316 3264 3267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 3329 3330 3280 3281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 3323 3330 3274 3281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 3332 3333 3283 3284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3342 3343 3293 3294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1772 1776 <span type="species:ncbi:10090">mice</span>
###xml 1900 1904 <span type="species:ncbi:10090">mice</span>
###xml 2628 2632 <span type="species:ncbi:10090">mice</span>
###xml 2662 2666 <span type="species:ncbi:10090">mice</span>
###xml 2791 2795 <span type="species:ncbi:10090">mice</span>
###xml 2851 2855 <span type="species:ncbi:10090">mice</span>
###xml 3268 3272 <span type="species:ncbi:10090">mice</span>
###xml 3317 3321 <span type="species:ncbi:10090">mice</span>
To examine the role of FFAR1 in acute fatty acid-stimulated insulin release, we used a selective beta3-adrenergic receptor agonist CL-316,243, which promotes lypolysis in rodent white adipose tissue (10). When administrated by intraperitoneal injection, CL-316,243 increases plasma free fatty acid levels within 5 min, which in turn rapidly increases plasma insulin levels (8). We injected saline and CL-316,243 (1 mg/kg) into Ffar1+/+ and Ffar1-/- mice, respectively, and collected blood samples to measure fatty acid and insulin levels. We used one-way ANOVA to assess the changes among the treatment groups. To test the differences between pairs of groups, we used t tests with Bonferroni corrections to adjust for multiple comparisons. As shown in Fig. 2, plasma fatty acid levels increased by approximately twofold in both Ffar1+/+ and Ffar1-/- mice in response to CL-316,243 injection (P < 0.01). There was no difference between Ffar1+/+ and Ffar1-/- mice in the CL-316,243-treated groups (P = 0.77, pairwise, two-tailed t test), indicating that beta-adrenergic receptor-mediated lipolysis in adipose tissue was not impaired in Ffar1-/- mice (Fig. 2A). In Ffar1+/+ mice, this increase of free fatty acid was accompanied by a approximately20-fold increase in plasma insulin level (Fig. 2B). In the Ffar1-/- mice, insulin levels were elevated about one-half as much as in the Ffar1+/+ mice despite a similar increase in fatty acids (Fig. 2B; P < 0.01, Ffar1+/+ CL-316,243 vs. Ffar1-/- CL-316,243, t test with Bonferroni correction). Similar results were obtained in two other independent experiments (data not shown). The data suggest that FFAR1 is responsible for approximately50% of fatty acid-stimulated insulin secretion. Amylin release was attenuated in Ffar1-/- mice as well, following the same pattern as that of insulin (Fig. 2C). The approximately10-fold increase of insulin in Ffar1-/- mice in response to CL-316,243 could conceivably be due to a direct stimulation of beta3-adrenergic receptor-mediated nerve signaling in the pancreatic islets, or it could be mediated indirectly through other adipose or gut-derived hormones, such as leptin or GLP-1. We examined whether leptin or GLP-1 release was affected by CL-316,243. Plasma leptin levels were unaffected (Fig. 2D, P = 0.61, ANOVA). For GLP-1, there was a significant difference among the treatment groups as assessed by ANOVA (P = 0.046); however, t tests failed to reach statistical significance after adjusting for multiple comparisons. Nevertheless, on pairwise comparison, GLP-1 levels increased by approximately twofold in CL-316,243-treated Ffar1+/+ mice compared with saline-treated mice (Fig. 2E; P = 0.02, Ffar1+/+ CL-316,243 vs. Ffar1+/+ saline, one-tailed t test). In the CL-316,243-treated groups, Ffar1-/- mice had lower GLP-1 levels when compared with the Ffar1+/+ mice (P = 0.04, Ffar1+/+ CL-316,243 vs. Ffar1-/- CL-316,243, one-tailed t test). Finally, because it was reported that FFAR1 is expressed and active in pancreatic alpha-cells (11), we tested the effect of CL-316,243 treatment on glucagon secretion. As shown in Fig. 2F, glucagon levels increased on CL-316,243 treatment (P < 0.05, t test with Bonferroni correction), and among the CL-316,243-treated groups, Ffar1-/- mice had lower glucagon levels than the Ffar1+/+ mice (Fig. 2F; P < 0.05, t test with Bonferroni correction).
###end p 26
###begin title 27
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Ffar1-/- mice were not protected from high-fat diet-induced metabolic complications.
###end title 27
###begin p 28
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 385 390 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 403 406 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 928 931 928 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 988 991 988 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1021 1022 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1015 1022 1015 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1118 1119 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1112 1119 1112 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1122 1127 1122 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1127 1130 1127 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1207 1212 1207 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1212 1215 1212 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1246 1247 1246 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1240 1247 1240 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1270 1275 1270 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1275 1278 1275 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1349 1350 1349 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1343 1350 1343 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1445 1446 1445 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1457 1458 1457 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1530 1531 1530 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1524 1531 1524 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1611 1616 1611 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1616 1619 1616 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1624 1629 1624 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1629 1632 1629 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1645 1646 1645 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1651 1652 1651 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1639 1652 1639 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic> and <italic>F</italic></xref>
###xml 1817 1818 1817 1818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1821 1826 1821 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1826 1829 1826 1829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1918 1919 1918 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1912 1919 1912 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>G</italic></xref>
###xml 1945 1946 1945 1946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1939 1946 1939 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>H</italic></xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
###xml 1131 1135 <span type="species:ncbi:10090">mice</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
###xml 1279 1283 <span type="species:ncbi:10090">mice</span>
###xml 1633 1637 <span type="species:ncbi:10090">mice</span>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
###xml 1830 1834 <span type="species:ncbi:10090">mice</span>
In light of the previous report by Steneberg et al. (5), we asked whether our Ffar1-/- mice are protected from developing insulin resistance under metabolic stress. We first carried out a pilot study using mice on a mixed B6/129 background and a modest high-fat diet (45% calories from fat; Research Diets). We failed to observe any difference in obesity-associated phenotypes between Ffar1+/+ and Ffar1-/- mice (data not shown). To test the possibility that different high-fat diet formulas might have led to a different phenotype than that observed by Steneberg et al. (5), we obtained the same diet they used (Surwit Diabetogenic Diet, 58% kcal Lard Diet; custom-made through Research Diets) and an appropriate control semipurified low-fat diet (D12450B; 10% of calories from fat; Research Diets). We placed five mice of each genotype (total 20 mice; 7-8 weeks old) on either a high-fat or low-fat diet for 8 weeks. The Ffar1-/- mice on the 10% low-fat diet were heavier than the Ffar1+/+ mice on the same diet (Fig. 3A), whereas the mice selected for 58% high-fat diet did not show a significant difference (Fig. 3B). Ffar1-/- mice had slightly but significantly higher accumulated food intake than the Ffar1+/+ mice on a low-fat diet (Fig. 3C). On a high-fat diet, Ffar1-/- mice also showed more accumulated food intake at weeks 2 and 3 (Fig. 3D); however, for the later time points, the differences did not reach statistical significance (P values by t tests were between 0.05 and 0.10 for each of those time points) (Fig. 3D). Throughout the time course, the body fat percentages were comparable between Ffar1+/+ and Ffar1-/- mice (Fig. 3E and F). Glucose tolerance and insulin tolerance tests were performed after the mice were put on a diet for 8 weeks. In contrast to what was reported by Steneberg et al. (5), Ffar1-/- mice did not exhibit improved glucose tolerance when fed either the low-fat diet (Fig. 3G) or high-fat diet (Fig. 3H).
###end p 28
###begin p 29
###xml 116 123 116 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 665 668 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 766 769 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 779 782 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 893 898 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 898 901 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1145 1146 1145 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1218 1223 1218 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1223 1226 1223 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1290 1291 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1300 1301 1300 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1339 1340 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1349 1350 1349 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1419 1424 1419 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1424 1427 1424 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1452 1453 1452 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1462 1463 1462 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1529 1534 1529 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1534 1537 1534 1537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1542 1547 1542 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1547 1550 1547 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1602 1607 1602 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1607 1610 1607 1610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1227 1231 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
###xml 1551 1555 <span type="species:ncbi:10090">mice</span>
###xml 1611 1615 <span type="species:ncbi:10090">mice</span>
At the end of the diet study, we measured plasma metabolic parameters using samples collected from terminal bleeds (Table 1). We used two-way ANOVA to analyze the differences attributed to diet and genotype effects. If there was a significant genotypic effect, we then used pairwise t tests to examine whether the difference was attributed to a low-fat diet or high-fat diet. We did not observe a diet or a genotypic effect on plasma glucose. The glucose levels were high in all the groups, likely as a result of postprandial terminal bleeding. There was a significant diet effect, but not a genotypic effect, on insulin (Table 1; P = 0.02). Both Ffar1+/+ and Ffar1-/- mice had comparable insulin levels on the high-fat diet, and the insulin levels between the Ffar1+/+ and Ffar1-/- mice on the low-fat diet were not significantly different (P = 0.11, pairwise t test). The data indicate that Ffar1-/- mice were not protected from high-fat diet-induced hyperinsulinemia. Plasma cholesterol levels were also higher in high-fat diet-fed mice, and there was no genotypic effect. Interestingly, there was a genotypic effect on plasma triglycerides (P = 0.02, two-way ANOVA). The effect was attributed to the fact that the Ffar1-/- mice had lower plasma triglyceride levels on the low-fat diet (P = 0.03, t test), but not on the high-fat diet (P = 0.31, t test). Conversely, the liver triglyceride levels were higher in the Ffar1-/- mice on a low-fat diet (P = 0.03, t test). High-fat diet increased liver triglyceride levels in both Ffar1+/+ and Ffar1-/- mice to a comparable level, so it is apparent that Ffar1-/- mice were not protected from high-fat diet-induced hepatic steatosis.
###end p 29
###begin p 30
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 421 424 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 446 449 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 636 642 636 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 742 743 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 730 743 730 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic> and <italic>B</italic></xref>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 801 804 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 830 831 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 836 837 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 824 837 824 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic> and <italic>D</italic></xref>
###xml 847 852 847 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 852 855 852 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 923 924 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 917 924 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 1053 1054 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1047 1054 1047 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>F</italic></xref>
###xml 1155 1156 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1165 1166 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1290 1295 1286 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1295 1298 1291 1294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1303 1308 1299 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1308 1311 1304 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1318 1325 1314 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 1410 1415 1406 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1415 1418 1411 1414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1423 1428 1419 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1428 1431 1424 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1490 1497 1486 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1515 1520 1511 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1520 1523 1516 1519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
###xml 1432 1436 <span type="species:ncbi:10090">mice</span>
###xml 1524 1528 <span type="species:ncbi:10090">mice</span>
Because we were unable to reproduce the phenotype of the Ffar1-/- mice using the 58% Surwit lard diet, we carried out a third high-fat diet study using a semipurified 60% high-fat diet from Research Diets. In addition, to eliminate contribution of a mixed genetic background, we further backcrossed our mice into a B6 background for more than 10 generations. Forty mice (Ffar1+/+ male, n = 11; Ffar1-/- male, n = 9; Ffar1+/+ female, n = 10; Ffar1-/- female, n = 10) at 6-8 weeks of age were placed on the 60% high-fat diet for 10 weeks. Metabolic characterization was performed before and after the high-fat diet treatment. As shown in Fig. 4, mice of both genotypes had similar weight gain during the course of high-fat feeding (Fig. 4A and B), and percentage of body fat did not differ between Ffar1+/+ and Ffar1-/- mice (Fig. 4C and D). Again, Ffar1-/- mice did not show improvement on the glucose tolerance test (Fig. 4E). No significant differences were observed between the genotypes at any of the time points in the insulin tolerance test (Fig. 4F), and the areas under the curves did not differ significantly (13,449 +/- 881 vs. 11,845 +/- 1,170, P = 0.28, t test). We also measured liver neutral lipid levels. The liver weights and liver triglyceride contents were similar between Ffar1+/+ and Ffar1-/- mice (Table 2). Although there were sex differences, no genotypic difference was observed between Ffar1+/+ and Ffar1-/- mice of either sex. The data are consistent with those in Table 1, confirming that Ffar1-/- mice were not protected from high-fat diet-induced hepatic steatosis.
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Free fatty acids represent something of a Jekyll and Hyde in regard to metabolic disease. Although an increase in plasma fatty acid serves as one of the nutritional cues leading to increased postprandial insulin secretion, the long-term elevation of plasma free fatty acids observed in obesity is thought to contribute to reduced insulin secretion and ultimately islet dysfunction and the development of type 2 diabetes. In this context, understanding the function of FFAR1 as a cell surface receptor for fatty acids becomes very important. To this end, we generated a line of Ffar1-/- mice to use as a tool in studying this receptor.
###end p 32
###begin p 33
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1114 1119 1114 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1119 1122 1119 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1235 1236 1235 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1334 1339 1334 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1339 1342 1339 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1347 1352 1347 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1352 1355 1352 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1420 1425 1420 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1425 1428 1425 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1435 1442 1435 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1719 1724 1719 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1724 1727 1724 1727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1793 1794 1793 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1864 1869 1864 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1869 1872 1869 1872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1933 1938 1933 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1938 1941 1938 1941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 604 619 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1032 1040 <span type="species:ncbi:9606">patients</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
###xml 1356 1360 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
###xml 1728 1732 <span type="species:ncbi:10090">mice</span>
###xml 1873 1877 <span type="species:ncbi:10090">mice</span>
###xml 1942 1946 <span type="species:ncbi:10090">mice</span>
The high-fat diet-induced phenotypes of our Ffar1-/- mice versus those reported by Steneberg et al. (5) were very different. In the Steneberg et al. (5) report, Ffar1-/- mice fed the high-fat diet gained similar weight and had reduced plasma glucose, insulin, and triglyceride levels compared with Ffar1+/+ mice. The mice also had dramatically reduced hepatic steatosis as shown by histological staining of a liver slice with oil red O. In addition, the mice were reported to show improved glucose tolerance or reduced glucose-stimulated insulin secretion and reduced hepatic glucose output. Conversely, transgenic mice overexpressing FFAR1 in pancreatic islets developed diabetes. This led Steneberg et al. (5) to suggest that FFAR1 is involved in the impairment of islet function induced by chronic exposure of elevated fatty acid associated with obesity. The data would also suggest that sustained signaling through FFAR1, such as that achieved by pharmacological activation with FFAR1 agonists, might be detrimental to diabetic patients. However, we were not able to reproduce the protective phenotypes in our Ffar1-/- mice using two distinct high-fat diets. Under the same high-fat diet formula as those used by Steneberg et al. (5), we observed that liver triglyceride and cholesterol accumulated to a comparable degree in both Ffar1+/+ and Ffar1-/- mice, and no reduction of hepatic steatosis was observed in the Ffar1-/- mice (Table 1). We reasoned that because the 58% Surwit diet lacks certain unsaturated fatty acids, it may not be the right diet to reflect a physiologically relevant setting. However, using a semipurified 60% high-fat diet, we still did not observe a reduction of hepatic steatosis in the Ffar1-/- mice. From the oil red O staining in the Steneberg et al. study (5), it was not clear whether the reduced liver fat accumulation in the Ffar1-/- mice was statistically significantly lower than that in the Ffar1+/+ mice.
###end p 33
###begin p 34
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 757 760 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 807 810 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 847 848 847 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 878 885 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 892 897 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 897 900 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 965 971 965 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 999 1004 999 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1004 1007 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1091 1092 1091 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1125 1130 1125 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1130 1133 1130 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1240 1245 1240 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1245 1248 1245 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1285 1290 1285 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1290 1293 1290 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1452 1457 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1457 1460 1457 1460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1623 1628 1623 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1628 1631 1628 1631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1711 1712 1711 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1294 1298 <span type="species:ncbi:10090">mice</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
###xml 1632 1636 <span type="species:ncbi:10090">mice</span>
The cause of the discrepancy between our study and that of Steneberg et al. (5) is not clear. One possibility may be a difference in genetic backgrounds. Our mice, although generated in a hybrid background, were backcrossed to B6 mice. The 58% high-fat diet study was carried out with mice that were backcrossed for six generations; the 60% high-fat diet study used mice backcrossed for >10 generations. The genetic background of the mice in the Steneberg et al. study (5) was reported as "backcrossed several generations." Another possibility is that FFAR1 may play a role maintaining basal metabolic homeostasis, but its effects are masked out by high-fat diet-induced metabolic stress. In our studies, we observed some detrimental phenotypes of the Ffar1-/- mice on a low-fat diet. For example, our Ffar1-/- mice had higher liver triglyceride (P = 0.03) on the low-fat diet (Table 1). The Ffar1-/- mice were also heavier, and they had slightly more food intake (Fig. 3). The results suggest that Ffar1-/- mice may have an unfavorable metabolic profile at basal conditions. Latour et al. (7) reported that 13-week-old male Ffar1-/- mice on chow diet had a significant albeit small degree of glucose intolerance. We speculate that because Ffar1-/- mice have a poorer profile than the Ffar1+/+ mice to begin with, when they reach the same metabolic endpoints on a high-fat diet, the high-fat diet-induced "net change" could be viewed as smaller in the Ffar1-/- mice, and the smaller change could be interpreted as resistance to a high-fat diet. However, it should be emphasized that, based on the detrimental phenotypes of Ffar1-/- mice in the present study and the glucose intolerance data from Latour et al. (7), deletion of FFAR1 does not decrease (rather, it likely increases) the risk of metabolic disease on either low-fat diet or high-fat diet.
###end p 34
###begin p 35
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 711 714 711 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 962 967 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 967 970 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1170 1175 1170 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1175 1178 1175 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1474 1479 1474 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1479 1482 1479 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1495 1496 1495 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1489 1496 1489 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>F</italic></xref>
###xml 1620 1622 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1483 1487 <span type="species:ncbi:10090">mice</span>
Another controversy in the literature is whether FFAR1 mediates the negative effects of chronic elevated fatty acids on insulin secretion and insulin resistance and whether FFAR1 links obesity and insulin resistance. Steneberg et al. (5) showed that insulin secretion from isolated Ffar1-/- islets was not impaired by 48-h exposure to palmitic acid and concluded that Ffar1-/- islets are protected from the long-term negative effect of fatty acids. They suggested that FFAR1 mediates the long-term negative effects of fatty acids and proposed that FFAR1 antagonism may represent a therapeutic strategy for obesity-associated type 2 diabetes. In contrast, Latour et al. (7) showed that isolated islets from Ffar1-/- mice were still subject to the impairment of the insulin response after chronic exposure to fatty acids and suggested that FFAR1 mediates the acute effect of fatty acids on insulin secretion but not the chronic, deleterious effects. Additionally, Ffar1-/- mice have approximately one-half the acute insulin secretion in vivo in response to a bolus of injected Intralipid. Although the objective of our study was to examine the effects of high-fat diet on Ffar1-/- mice, we did confirm that FFAR1 mediates acute fatty acid-stimulated insulin release in vivo. FFAR1 does not play a role in adipose tissue lipolysis or leptin release, but it can affect GLP-1 level. Finally, CL-316,243 treatment stimulated glucagon release, and such an effect was attenuated in Ffar1-/- mice (Fig. 3F), supporting a previous report that FFAR1 is expressed in glucagon-producing cells and that it affects glucagon secretion (11).
###end p 35
###begin p 36
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Diabetes</italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 904 907 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 990 993 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1079 1084 1079 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1084 1087 1084 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 1276 1281 1276 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1281 1284 1281 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1420 1425 1420 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1425 1428 1425 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1473 1478 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1478 1481 1478 1481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1285 1289 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
While the present manuscript was in revision, three new studies appeared in press in Diabetes addressing the roles of GPR40/FFAR1 in insulin secretion and metabolic homeostasis. The first study by Tan et al. (12) showed that selective small-molecule agonists of FFAR1 promoted glucose-dependent insulin secretion and reduced blood glucose in Ffar1+/+ but not in Ffar1-/- mice, and they concluded that FFAR1 does not mediate the long-term effects of fatty acids on islet function. Our results support these findings. The second study by Edfalk et al. (13) showed that Ffar1 is expressed in enteroendocrine cells and mediates fatty acid stimulation of incretin secretion. Our data support a possible involvement of FFAR1 in fatty acid-mediated GLP-1 secretion. Finally, the study by Kebede et al. (14) examined the role of FFAR1 in insulin secretion in vivo after high-fat feeding. They reported that Ffar1-/- mice had fasting hyperglycemia despite normal glucose and insulin tolerance. Ffar1-/- mice became as obese, became as glucose intolerant and as insulin resistant as their Ffar1+/+ littermates under high-fat diet (60% fat), and developed a similar degree of liver steatosis (14). Our results are consistent with those in the Kebede et al. study (14). We also show that Ffar1-/- mice had slightly more food intake and body weight on a low-fat diet. In addition, we provide quantitative data showing that livers of Ffar1-/- mice accumulate no less neutral lipids than Ffar1+/+ littermates under either low-fat diet or high-fat diet.
###end p 36
###begin p 37
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
In conclusion, the present study demonstrates that FFAR1 contributes to the maintenance of basal metabolism and that deletion of FFAR1 does not protect mice from high-fat diet-induced metabolic disease. Our results, along with those of the recently published studies (7,12-14), jointly argue that antagonists of FFAR1 may not provide significant benefit for obesity-associated type 2 diabetes.
###end p 37
###begin p 38
Schering-Plough Research Institute is fully funded by Schering-Plough Corporation.
###end p 38
###begin p 39
###xml 90 94 <span type="species:ncbi:163112">Ling</span>
###xml 135 142 <span type="species:ncbi:15957">Timothy</span>
We are grateful for the technical support from Andrei Golovko on gene expression and from Ling Pang on insulin analysis. We thank Drs. Timothy Kowalski and Ruth Duffy for critical discussions and Drs. Marvin Bayne and Michael Graziano for administrative support.
###end p 39
###begin title 40
REFERENCES
###end title 40
###begin p 41
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 255 267 255 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 480 483 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 637 645 637 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>+/+</sup></italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 660 661 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 661 662 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 662 663 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 804 807 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 799 807 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>+/+</sup></italic>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 822 824 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/</sup>
###xml 824 825 824 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
Generation of Ffar1-/- mice. A: Schematic view of the regions depleted in Ffar1 gene. A 152-bp fragment corresponding to position 143-294 of the open reading frame of the Ffar1 gene (NM_194057) was replaced by a neo cassette. The two black bars below the bottom panel represent the positions of the 5' and 3' probes used for Southern blotting. B: Southern blotting of ES cell clones. Shown are DNA samples from two nontargeted ES clones and a targeted clone (ES 1315) digested by EcoRV and probed with a 5' probe and by HindIII and probed with a 3' probe, respectively. C: Representative PCR genotyping of DNA samples from tail clips of Ffar1+/+ (WT) and Ffar1-/- (KO) mice. The WT allele is 234 bp and the KO allele is 399 bp in size. D: Expression of Ffar1 mRNA in pancreatic islets and spleen of Ffar1+/+ (WT) and Ffar1-/- (KO) mice accessed by real-time quantitative PCR.
###end p 41
###begin p 42
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>+/+</sup></italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/</sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 213 216 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 208 216 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>+/+</sup></italic>
###xml 245 248 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 240 248 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>+/+</sup></italic>
###xml 281 284 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 276 284 273 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>&#8722;/&#8722;</sup></italic>
###xml 317 320 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 312 320 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1<sup>&#8722;/&#8722;</sup></italic>
###xml 348 349 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 372 373 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 393 394 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 405 406 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 416 417 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 427 428 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 449 450 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 513 514 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 550 551 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 562 563 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">Mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
Plasma parameters of Ffar1+/+ and Ffar1-/- mice in response to beta3 agonist CL-316,243 (CL) injections. Mice received intraperitoneal injection of either saline or CL-316,243. The four treatment groups are: Ffar1+/+ mice receiving saline, Ffar1+/+ mice receiving CL-316,243, Ffar1-/- mice receiving saline, and Ffar1-/- mice receiving CL-316,243. n = 5-8 mice per group. A: Free fatty acids. B: Insulin. C: Amylin. D: Leptin. E: GLP-1 (7-36)amide. F: Glucagon. The data are analyzed by one-way ANOVA followed by t tests with Bonferroni correction. *P < 0.05; **P < 0.01.
###end p 42
###begin p 43
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 635 636 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 742 743 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 870 871 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 959 960 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 969 970 967 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 986 991 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 991 994 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 999 1004 997 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 1004 1007 1002 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
Metabolic characterizations of Ffar1+/+ and Ffar1-/- mice after 8 weeks on a low-fat diet and high-fat diet. Ffar1+/+ and Ffar1-/- mice at N6 generation of backcrossing into B6 background were fed for 8 weeks on a Surwit diabetogenic diet (58% of calories from lard) or a semipurified low-fat diet (10% of calories from fat) ad libitum. n = 5 mice per group. Body weight and body fat were monitored biweekly. Food intake was measured weekly. Glucose tolerance tests (GTT) were performed before mice were killed for blood samples and tissue collection. A: Body weight of low-fat diet-fed mice. B: Body weight of high-fat diet-fed mice. C: Accumulated food intake of low-fat diet-fed mice. D: Accumulated food intake of high-fat diet-fed mice. E: Body fat of low-fat diet-fed mice. F: Body fat of low-fat diet-fed mice. G: Glucose tolerance test of low-fat diet-fed mice. H: Glucose tolerance test of low-fat diet-fed mice. Data are presented as means +/- SE. *P < 0.05, t test comparing Ffar1+/+ and Ffar1-/- mice at each time point.
###end p 43
###begin p 44
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 319 322 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 670 671 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
Metabolic characterizations of Ffar1+/+ and Ffar1-/- mice after 10 weeks on 60% high-fat diet (HFD). Ffar1+/+ and Ffar1-/- mice after 10 generations of backcrossing into B6 background were fed for 10 weeks on semipurified high-fat diet (60% calories from fat). n = 11, Ffar1+/+ male; n = 9, Ffar1-/- male; n = 10, Ffar1+/+ female; n = 10, Ffar1-/- female. Body weight was monitored weekly, and body fat was assessed every 4 weeks. Glucose tolerance tests (GTT) and insulin tolerance tests (ITT) were performed at the end of the study. A: Body weight of male mice. B: Body weight of female mice. C: Body fat of male mice. D: Body fat of female mice. E: GTT of male mice. F: ITT of male mice. Data are presented as means +/- SE.
###end p 44
###begin p 45
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Plasma and liver parameters of Ffar1+/+ and Ffar1-/- mice after 8 weeks on 10% low-fat diet and 58% high-fat diet
###end p 45
###begin p 46
###xml 27 28 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are means +/- SE. The P values are generated by two-way ANOVA testing diet and genotype effects.
###end p 46
###begin p 47
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ffar1</italic>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Liver lipids of Ffar1+/+ and Ffar1-/- mice after 10 weeks on a 60% high-fat diet
###end p 47
###begin p 48
###xml 27 28 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are means +/- SE. The P values are generated by two-way ANOVA testing sex and genotype effect.
###end p 48

